Literature DB >> 9253565

Comparison between the Ovassapian intubating airway and the Berman intubating airway in fibreoptic intubation.

T Randell1, H Valli, P Hakala.   

Abstract

The most common indication for employing the fibreoptic technique for intubation is when a difficult intubation is anticipated. It may also be used when intubation unexpectedly proves difficult with a rigid laryngoscope in anaesthetized patients. However, failures with orotracheal fibreoptic intubation have been reported in up to 9.5% of cases, although only two possible equipment related causes of intubation difficulties have been identified. The Berman intubating airway and the Ovassapian intubation airway in fibreoptic orotracheal intubation have been compared in 65 patients. The study was randomized and for fibreoptic endoscopy each patient served as his or her own control. The results indicate that both airways can be used for orotracheal fibreoptic intubation in anaesthetized patients. The Berman airway offers easier visualization of the vocal cords than the Ovassapian airway, provided that the Berman airway is of an adequate size and positioned in the midline. Upon impingement of the intubation tube, completing the tracheal intubation is more difficult with the Berman airway than the Ovassapian airway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9253565     DOI: 10.1046/j.1365-2346.1997.00134.x

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  2 in total

1.  Awake fiberoptic orotracheal intubation: a protocol feasibility study.

Authors:  Yuanyuan Ma; Xue Cao; Hong Zhang; Shengjin Ge
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

2.  A fiberoptic orotracheal intubation successfully performed using a modified Guedel airway in a sedated emergency patient - A case report.

Authors:  Jaeyoung Yang; Seonjin Kim; Bousung Lee; Kwanghaeng Lee; Dongseok Kim; Jaedo Lee; Hee Jung Jun; Jin Sun Yoon; Sam Soon Cho
Journal:  Anesth Pain Med (Seoul)       Date:  2020-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.